Tacrolimus and cyclosporine efficacy in high-risk kidney transplantation on behalf of the European Multicentre Tacrolimus (FK506) Renal Study Group
- 1 June 1998
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 11 (s1) , S73-S77
- https://doi.org/10.1111/j.1432-2277.1998.tb01200.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1Transplantation, 1997
- IMPACT OF ACUTE REJECTION AND EARLY ALLOGRAFT FUNCTION ON RENAL ALLOGRAFT SURVIVALTransplantation, 1997
- A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1997
- Cadaveric renal transplantation against a positive crossmatch under tacrolimus immunosuppression: Long-term follow-upTransplantation Proceedings, 1997
- A MULTICENTER TRIAL OF FK506 (TACROLIMUS) THERAPY IN REFRACTORY ACUTE RENAL ALLOGRAFT REJECTIONTransplantation, 1996
- ONE-YEAR FOLLOW-UP OF AN OPEN-LABEL TRIAL OF FK506 FOR PRIMARY KIDNEY TRANSPLANTATION1Transplantation, 1996
- HOW BEST TO USE TACROLIMUS (FK506) FOR TREATMENT OF STEROID- AND OKT3-RESISTANT REJECTION AFTER RENAL TRANSPLANTATIONTransplantation, 1996
- A PROSPECTIVE RANDOMIZED TRIAL OF FK506-BASED IMMUNOSUPPRESSION AFTER RENAL TRANSPLANTATION1Transplantation, 1995
- FK506 “RESCUE” FOR RESISTANT REJECTION OF RENAL ALLOGRAFTS UNDER PRIMARY CYCLOSPORINE IMMUNOSUPPRESSION1Transplantation, 1994
- THE IMPACT OF ACUTE REJECTION EPISODES ON LONG-TERM GRAFT FUNCTION AND OUTCOME IN 1347 PRIMARY RENAL TRANSPLANTS TREATED BY 3 CYCLOSPORINE REGIMENSTransplantation, 1993